Global Hodgkin's Lymphoma Therapeutics Market Research Report 2023

Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing the condition is increased if a person suffers from a medical condition that weakens the immune system. In HL, cells in the lymphatic system grow unusually and may spread beyond the lymphatic system. The infection-fighting properties of the lymphocytes are lost, making the person more susceptible to infection. The main treatments used are chemotherapy, followed by radiotherapy or chemotherapy alone. Generally surgery is not used as a treatment for the condition.

The global Hodgkin's Lymphoma Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The Hodgkin’s lymphoma therapeutics pipeline is expected to witness considerable growth in the coming years as the researchers are making novel drug delivery system for the treatment for cancer. The government agencies such as National Cancer Institute and American Cancer Society are supporting the growth of the Hodgkin’s lymphoma (HL) therapeutics pipeline by providing funding, designations and grants for speeding up the drug development process. High prevalence of cancer, increasing awareness regarding cancer treatment, technological advancements and high demand for safe and effective medication are driving the growth of the Hodgkin’s Lymphoma therapeutics pipeline.

This report aims to provide a comprehensive presentation of the global market for Hodgkin's Lymphoma Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hodgkin's Lymphoma Therapeutics.

The Hodgkin's Lymphoma Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Hodgkin's Lymphoma Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hodgkin's Lymphoma Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Hodgkin's Lymphoma Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Alkylating Antineoplastic Agents

1.2.3 Antibiotic Antineoplastic Agents

1.2.4 Antineoplastics Vinca Alkaloid Agents

1.2.5 Podophyllotoxin Derivative Antineoplastic Agents

1.2.6 Antimetabolite Antineoplastic Agents

1.2.7 Anthracycline Antineoplastic Agents

1.2.8 Antimicrotubular Antineoplastics

1.2.9 Corticosteroids

1.3 Market by Application

1.3.1 Global Hodgkin's Lymphoma Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Academic and Research Institutes

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Hodgkin's Lymphoma Therapeutics Market Perspective (2018-2029)

2.2 Hodgkin's Lymphoma Therapeutics Growth Trends by Region

2.2.1 Global Hodgkin's Lymphoma Therapeutics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Hodgkin's Lymphoma Therapeutics Historic Market Size by Region (2018-2023)

2.2.3 Hodgkin's Lymphoma Therapeutics Forecasted Market Size by Region (2024-2029)

2.3 Hodgkin's Lymphoma Therapeutics Market Dynamics

2.3.1 Hodgkin's Lymphoma Therapeutics Industry Trends

2.3.2 Hodgkin's Lymphoma Therapeutics Market Drivers

2.3.3 Hodgkin's Lymphoma Therapeutics Market Challenges

2.3.4 Hodgkin's Lymphoma Therapeutics Market Restraints

3.1 Global Top Hodgkin's Lymphoma Therapeutics Players by Revenue

3.1.1 Global Top Hodgkin's Lymphoma Therapeutics Players by Revenue (2018-2023)

3.1.2 Global Hodgkin's Lymphoma Therapeutics Revenue Market Share by Players (2018-2023)

3.2 Global Hodgkin's Lymphoma Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Hodgkin's Lymphoma Therapeutics Revenue

3.4 Global Hodgkin's Lymphoma Therapeutics Market Concentration Ratio

3.4.1 Global Hodgkin's Lymphoma Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Hodgkin's Lymphoma Therapeutics Revenue in 2022

3.5 Hodgkin's Lymphoma Therapeutics Key Players Head office and Area Served

3.6 Key Players Hodgkin's Lymphoma Therapeutics Product Solution and Service

3.7 Date of Enter into Hodgkin's Lymphoma Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Hodgkin's Lymphoma Therapeutics Historic Market Size by Type (2018-2023)

4.2 Global Hodgkin's Lymphoma Therapeutics Forecasted Market Size by Type (2024-2029)

5.1 Global Hodgkin's Lymphoma Therapeutics Historic Market Size by Application (2018-2023)

5.2 Global Hodgkin's Lymphoma Therapeutics Forecasted Market Size by Application (2024-2029)

6.1 North America Hodgkin's Lymphoma Therapeutics Market Size (2018-2029)

6.2 North America Hodgkin's Lymphoma Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Hodgkin's Lymphoma Therapeutics Market Size by Country (2018-2023)

6.4 North America Hodgkin's Lymphoma Therapeutics Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Hodgkin's Lymphoma Therapeutics Market Size (2018-2029)

7.2 Europe Hodgkin's Lymphoma Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Hodgkin's Lymphoma Therapeutics Market Size by Country (2018-2023)

7.4 Europe Hodgkin's Lymphoma Therapeutics Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Hodgkin's Lymphoma Therapeutics Market Size (2018-2029)

8.2 Asia-Pacific Hodgkin's Lymphoma Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Hodgkin's Lymphoma Therapeutics Market Size by Region (2018-2023)

8.4 Asia-Pacific Hodgkin's Lymphoma Therapeutics Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Hodgkin's Lymphoma Therapeutics Market Size (2018-2029)

9.2 Latin America Hodgkin's Lymphoma Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Hodgkin's Lymphoma Therapeutics Market Size by Country (2018-2023)

9.4 Latin America Hodgkin's Lymphoma Therapeutics Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Hodgkin's Lymphoma Therapeutics Market Size (2018-2029)

10.2 Middle East & Africa Hodgkin's Lymphoma Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Hodgkin's Lymphoma Therapeutics Market Size by Country (2018-2023)

10.4 Middle East & Africa Hodgkin's Lymphoma Therapeutics Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Bristol Myers Squibb

11.1.1 Bristol Myers Squibb Company Detail

11.1.2 Bristol Myers Squibb Business Overview

11.1.3 Bristol Myers Squibb Hodgkin's Lymphoma Therapeutics Introduction

11.1.4 Bristol Myers Squibb Revenue in Hodgkin's Lymphoma Therapeutics Business (2018-2023)

11.1.5 Bristol Myers Squibb Recent Development

11.2 F. Hoffmann-La Roche

11.2.1 F. Hoffmann-La Roche Company Detail

11.2.2 F. Hoffmann-La Roche Business Overview

11.2.3 F. Hoffmann-La Roche Hodgkin's Lymphoma Therapeutics Introduction

11.2.4 F. Hoffmann-La Roche Revenue in Hodgkin's Lymphoma Therapeutics Business (2018-2023)

11.2.5 F. Hoffmann-La Roche Recent Development

11.3 Merck

11.3.1 Merck Company Detail

11.3.2 Merck Business Overview

11.3.3 Merck Hodgkin's Lymphoma Therapeutics Introduction

11.3.4 Merck Revenue in Hodgkin's Lymphoma Therapeutics Business (2018-2023)

11.3.5 Merck Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Detail

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Hodgkin's Lymphoma Therapeutics Introduction

11.4.4 Pfizer Revenue in Hodgkin's Lymphoma Therapeutics Business (2018-2023)

11.4.5 Pfizer Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Hodgkin's Lymphoma Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Alkylating Antineoplastic Agents

    Table 3. Key Players of Antibiotic Antineoplastic Agents

    Table 4. Key Players of Antineoplastics Vinca Alkaloid Agents

    Table 5. Key Players of Podophyllotoxin Derivative Antineoplastic Agents

    Table 6. Key Players of Antimetabolite Antineoplastic Agents

    Table 7. Key Players of Anthracycline Antineoplastic Agents

    Table 8. Key Players of Antimicrotubular Antineoplastics

    Table 9. Key Players of Corticosteroids

    Table 10. Global Hodgkin's Lymphoma Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 11. Global Hodgkin's Lymphoma Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 12. Global Hodgkin's Lymphoma Therapeutics Market Size by Region (2018-2023) & (US$ Million)

    Table 13. Global Hodgkin's Lymphoma Therapeutics Market Share by Region (2018-2023)

    Table 14. Global Hodgkin's Lymphoma Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 15. Global Hodgkin's Lymphoma Therapeutics Market Share by Region (2024-2029)

    Table 16. Hodgkin's Lymphoma Therapeutics Market Trends

    Table 17. Hodgkin's Lymphoma Therapeutics Market Drivers

    Table 18. Hodgkin's Lymphoma Therapeutics Market Challenges

    Table 19. Hodgkin's Lymphoma Therapeutics Market Restraints

    Table 20. Global Hodgkin's Lymphoma Therapeutics Revenue by Players (2018-2023) & (US$ Million)

    Table 21. Global Hodgkin's Lymphoma Therapeutics Market Share by Players (2018-2023)

    Table 22. Global Top Hodgkin's Lymphoma Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hodgkin's Lymphoma Therapeutics as of 2022)

    Table 23. Ranking of Global Top Hodgkin's Lymphoma Therapeutics Companies by Revenue (US$ Million) in 2022

    Table 24. Global 5 Largest Players Market Share by Hodgkin's Lymphoma Therapeutics Revenue (CR5 and HHI) & (2018-2023)

    Table 25. Key Players Headquarters and Area Served

    Table 26. Key Players Hodgkin's Lymphoma Therapeutics Product Solution and Service

    Table 27. Date of Enter into Hodgkin's Lymphoma Therapeutics Market

    Table 28. Mergers & Acquisitions, Expansion Plans

    Table 29. Global Hodgkin's Lymphoma Therapeutics Market Size by Type (2018-2023) & (US$ Million)

    Table 30. Global Hodgkin's Lymphoma Therapeutics Revenue Market Share by Type (2018-2023)

    Table 31. Global Hodgkin's Lymphoma Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 32. Global Hodgkin's Lymphoma Therapeutics Revenue Market Share by Type (2024-2029)

    Table 33. Global Hodgkin's Lymphoma Therapeutics Market Size by Application (2018-2023) & (US$ Million)

    Table 34. Global Hodgkin's Lymphoma Therapeutics Revenue Market Share by Application (2018-2023)

    Table 35. Global Hodgkin's Lymphoma Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 36. Global Hodgkin's Lymphoma Therapeutics Revenue Market Share by Application (2024-2029)

    Table 37. North America Hodgkin's Lymphoma Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 38. North America Hodgkin's Lymphoma Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 39. North America Hodgkin's Lymphoma Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 40. Europe Hodgkin's Lymphoma Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Europe Hodgkin's Lymphoma Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Europe Hodgkin's Lymphoma Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Asia-Pacific Hodgkin's Lymphoma Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Asia-Pacific Hodgkin's Lymphoma Therapeutics Market Size by Region (2018-2023) & (US$ Million)

    Table 45. Asia-Pacific Hodgkin's Lymphoma Therapeutics Market Size by Region (2024-2029) & (US$ Million)

    Table 46. Latin America Hodgkin's Lymphoma Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 47. Latin America Hodgkin's Lymphoma Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 48. Latin America Hodgkin's Lymphoma Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 49. Middle East & Africa Hodgkin's Lymphoma Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 50. Middle East & Africa Hodgkin's Lymphoma Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 51. Middle East & Africa Hodgkin's Lymphoma Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 52. Bristol Myers Squibb Company Detail

    Table 53. Bristol Myers Squibb Business Overview

    Table 54. Bristol Myers Squibb Hodgkin's Lymphoma Therapeutics Product

    Table 55. Bristol Myers Squibb Revenue in Hodgkin's Lymphoma Therapeutics Business (2018-2023) & (US$ Million)

    Table 56. Bristol Myers Squibb Recent Development

    Table 57. F. Hoffmann-La Roche Company Detail

    Table 58. F. Hoffmann-La Roche Business Overview

    Table 59. F. Hoffmann-La Roche Hodgkin's Lymphoma Therapeutics Product

    Table 60. F. Hoffmann-La Roche Revenue in Hodgkin's Lymphoma Therapeutics Business (2018-2023) & (US$ Million)

    Table 61. F. Hoffmann-La Roche Recent Development

    Table 62. Merck Company Detail

    Table 63. Merck Business Overview

    Table 64. Merck Hodgkin's Lymphoma Therapeutics Product

    Table 65. Merck Revenue in Hodgkin's Lymphoma Therapeutics Business (2018-2023) & (US$ Million)

    Table 66. Merck Recent Development

    Table 67. Pfizer Company Detail

    Table 68. Pfizer Business Overview

    Table 69. Pfizer Hodgkin's Lymphoma Therapeutics Product

    Table 70. Pfizer Revenue in Hodgkin's Lymphoma Therapeutics Business (2018-2023) & (US$ Million)

    Table 71. Pfizer Recent Development

    Table 72. Research Programs/Design for This Report

    Table 73. Key Data Information from Secondary Sources

    Table 74. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Hodgkin's Lymphoma Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Hodgkin's Lymphoma Therapeutics Market Share by Type: 2022 VS 2029

    Figure 3. Alkylating Antineoplastic Agents Features

    Figure 4. Antibiotic Antineoplastic Agents Features

    Figure 5. Antineoplastics Vinca Alkaloid Agents Features

    Figure 6. Podophyllotoxin Derivative Antineoplastic Agents Features

    Figure 7. Antimetabolite Antineoplastic Agents Features

    Figure 8. Anthracycline Antineoplastic Agents Features

    Figure 9. Antimicrotubular Antineoplastics Features

    Figure 10. Corticosteroids Features

    Figure 11. Global Hodgkin's Lymphoma Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 12. Global Hodgkin's Lymphoma Therapeutics Market Share by Application: 2022 VS 2029

    Figure 13. Hospitals Case Studies

    Figure 14. Academic and Research Institutes Case Studies

    Figure 15. Hodgkin's Lymphoma Therapeutics Report Years Considered

    Figure 16. Global Hodgkin's Lymphoma Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 17. Global Hodgkin's Lymphoma Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 18. Global Hodgkin's Lymphoma Therapeutics Market Share by Region: 2022 VS 2029

    Figure 19. Global Hodgkin's Lymphoma Therapeutics Market Share by Players in 2022

    Figure 20. Global Top Hodgkin's Lymphoma Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hodgkin's Lymphoma Therapeutics as of 2022)

    Figure 21. The Top 10 and 5 Players Market Share by Hodgkin's Lymphoma Therapeutics Revenue in 2022

    Figure 22. North America Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. North America Hodgkin's Lymphoma Therapeutics Market Share by Country (2018-2029)

    Figure 24. United States Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Canada Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Europe Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Europe Hodgkin's Lymphoma Therapeutics Market Share by Country (2018-2029)

    Figure 28. Germany Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. France Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. U.K. Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Italy Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Russia Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Nordic Countries Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Asia-Pacific Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Asia-Pacific Hodgkin's Lymphoma Therapeutics Market Share by Region (2018-2029)

    Figure 36. China Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Japan Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. South Korea Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Southeast Asia Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. India Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Australia Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Latin America Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Latin America Hodgkin's Lymphoma Therapeutics Market Share by Country (2018-2029)

    Figure 44. Mexico Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Brazil Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Middle East & Africa Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Middle East & Africa Hodgkin's Lymphoma Therapeutics Market Share by Country (2018-2029)

    Figure 48. Turkey Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Saudi Arabia Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 50. Bristol Myers Squibb Revenue Growth Rate in Hodgkin's Lymphoma Therapeutics Business (2018-2023)

    Figure 51. F. Hoffmann-La Roche Revenue Growth Rate in Hodgkin's Lymphoma Therapeutics Business (2018-2023)

    Figure 52. Merck Revenue Growth Rate in Hodgkin's Lymphoma Therapeutics Business (2018-2023)

    Figure 53. Pfizer Revenue Growth Rate in Hodgkin's Lymphoma Therapeutics Business (2018-2023)

    Figure 54. Bottom-up and Top-down Approaches for This Report

    Figure 55. Data Triangulation

    Figure 56. Key Executives Interviewed